In DSS-induced IBD models, polysaccharides from Lycium barbarum LBP, AAP, and CMP have been shown to suppress the NF-κB pathway, thereby inhibiting intestinal inflammation [34,47,48]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.